These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19555824

  • 1. Medical treatment of Parkinson disease.
    Stacy M.
    Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824
    [Abstract] [Full Text] [Related]

  • 2. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
    Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE, PD MED Collaborative Group.
    JAMA Neurol; 2022 Feb 01; 79(2):131-140. PubMed ID: 34962574
    [Abstract] [Full Text] [Related]

  • 3. Treatment of levodopa-induced motor complications.
    Stocchi F, Tagliati M, Olanow CW.
    Mov Disord; 2008 Feb 01; 23 Suppl 3():S599-612. PubMed ID: 18781681
    [Abstract] [Full Text] [Related]

  • 4. Pharmacotherapy of Parkinson's disease: research from 1960 to 1991.
    Pletscher A, DaPrada M.
    Acta Neurol Scand Suppl; 1993 Feb 01; 146():26-31. PubMed ID: 8101413
    [Abstract] [Full Text] [Related]

  • 5. Treatment of early Parkinson's disease. Part 1.
    Simuni T, Lyons KE, Pahwa R, Hauser RA, Comella C, Elmer L, Weintraub D.
    Eur Neurol; 2009 Feb 01; 61(4):193-205. PubMed ID: 19176960
    [Abstract] [Full Text] [Related]

  • 6. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
    Olanow CW.
    Mov Disord; 2008 Feb 01; 23 Suppl 3():S613-22. PubMed ID: 18781663
    [Abstract] [Full Text] [Related]

  • 7. Parkinson's disease--levodopa complications.
    King DB.
    Can J Neurol Sci; 1999 Aug 01; 26 Suppl 2():S13-20. PubMed ID: 10451755
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological treatment of Parkinson's disease.
    Münchau A, Bhatia KP.
    Postgrad Med J; 2000 Oct 01; 76(900):602-10. PubMed ID: 11009573
    [No Abstract] [Full Text] [Related]

  • 9. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
    Oertel W, Schulz JB.
    J Neurochem; 2016 Oct 01; 139 Suppl 1():325-337. PubMed ID: 27577098
    [Abstract] [Full Text] [Related]

  • 10. [Treatment in Parkinson disease].
    Takáts A.
    Orv Hetil; 2004 Apr 11; 145(15):833-4. PubMed ID: 15188639
    [No Abstract] [Full Text] [Related]

  • 11. [Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].
    Pagonabarraga J, Kulisevsky J.
    Rev Neurol; 2014 Jan 01; 58(1):25-34. PubMed ID: 24343538
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alternatives to levodopa in the initial treatment of early Parkinson's disease.
    Lees A.
    Drugs Aging; 2005 Jan 01; 22(9):731-40. PubMed ID: 16156677
    [Abstract] [Full Text] [Related]

  • 14. Treatment options for early Parkinson's disease.
    Stacy M, Brownlee HJ.
    Am Fam Physician; 1996 Mar 01; 53(4):1281-7. PubMed ID: 8629572
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease.
    Ruggieri S, Fabbrini G, Bramante L, DePandis F, Stocchi F, Barbanti P, Vacca L, Manfredi M.
    Adv Neurol; 1996 Mar 01; 69():595-8. PubMed ID: 8615185
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Not Available].
    Grabli D.
    Presse Med; 2017 Mar 01; 46(2 Pt 1):187-194. PubMed ID: 28233705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.